Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics

Journal of the Neurological Sciences

Volumn 346, Issue 1-2, 2014, Pages 138-144

  Zhu, De Sheng ^a   Fu, Jue ^b   Zhang, Yue ^c   Li, Shi Xu ^c   Zhang, Guang Xian ^d   Guan, Yang Tai ^c   Dong, Qiang ^a  

^a FUDAN UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Central nervous system; Clinical features; Neuroimaging; Pathology

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; AZATHIOPRINE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BRAIN BIOPSY; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATION; DIAGNOSTIC ERROR; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE VENOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOEMBOLISM; AGE; BIOPSY; BRAIN; COMPLICATION; DEMYELINATING DISEASE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; SKIN;

ADULT; AGE FACTORS; ANTIPHOSPHOLIPID SYNDROME; BIOPSY; BRAIN; DEMYELINATING DISEASES; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SKIN; THROMBOEMBOLISM;

EID: 84910122192     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.08.010     Document Type: Article

References (38)

1. J.A. Gomez-Puerta, and R. Cervera Diagnosis and classification of the antiphospholipid syndrome J Autoimmun 48-49 2014 20 25
2. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (aps) J Thromb Haemost 4 2006 295 306
3. W.A. Wilson, A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, and J.C. Piette International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum 42 1999 1309 1311
4. R.A. Asherson, R. Cervera, P.G. de Groot, D. Erkan, M.C. Boffa, and J.C. Piette Catastrophic Antiphospholipid Syndrome Registry Project G. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines Lupus 12 2003 530 534
5. M.L. Boey, C.B. Colaco, A.E. Gharavi, K.B. Elkon, S. Loizou, and G.R. Hughes Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant Br Med J (Clin Res Ed) 287 1983 1021 1023
6. R. Cervera, R. Serrano, G.J. Pons-Estel, L. Ceberio-Hualde, Y. Shoenfeld, and E. de Ramon On behalf of the Euro-Phospholipid Project G. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients Ann Rheum Dis 2014 Jan 24 10.1136/annrheumdis-2013-204838 [Epub ahead of print]
7. A. Matyja-Bednarczyk, J. Swadzba, T. Iwaniec, M. Sanak, S. Dziedzina, and A. Cmiel Risk factors for arterial thrombosis in antiphospholipid syndrome Thromb Res 133 2014 173 176
8. L. Ziporen, S. Polak-Charcon, D.A. Korczyn, I. Goldberg, A. Afek, and J. Kopolovic Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model Clin Dev Immunol 11 2004 67 75
9. C. Nalli, L. Andreoli, C. Casu, and A. Tincani Management of recurrent thrombosis in antiphospholipid syndrome Curr Rheumatol Rep 16 2014 405
10. D. Erkan, C.L. Aguiar, D. Andrade, H. Cohen, M.J. Cuadrado, and A. Danowski 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends Autoimmun Rev 13 2014 685 696
11. E. Muscal, and R.L. Brey Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine Int J Clin Pract 61 2007 1561 1568
12. D. Erkan, and M.D. Lockshin Aps action-antiphospholipid syndrome alliance for clinical trials and international networking Lupus 21 2012 695 698
13. I. Les, G. Ruiz-Irastorza, and M.A. Khamashta Intensity and duration of anticoagulation therapy in antiphospholipid syndrome Semin Thromb Hemost 38 2012 339 347
14. S. Sciascia, G. Sanna, V. Murru, D. Roccatello, M.A. Khamashta, and M.L. Bertolaccini Anti-prothrombin (apt) and anti-phosphatidylserine/prothrombin (aps/pt) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review Thromb Haemost 111 2014 354 364
15. D. Keeling, I. Mackie, G.W. Moore, I.A. Greer, and M. Greaves British Committee for Standards in H. Guidelines on the investigation and management of antiphospholipid syndrome Br J Haematol 157 2012 47 58
16. R. Cervera, J.C. Piette, J. Font, M.A. Khamashta, Y. Shoenfeld, and M.T. Camps Euro-Phospholipid Project G: antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 46 2002 1019 1027
17. E.J. Favaloro, and R.C. Wong The antiphospholipid syndrome: diagnosis, pathogenesis, laboratory testing, and management Semin Thromb Hemost 38 2012 299 304
18. A.L. Suarez, G.R. Hughes, and M.A. Khamashta Neurological manifestations of the antiphospholipid syndrome Med Clin (Barc) 124 2005 630 633
19. M.T. Bertero, M. Bazzan, R. Carignola, B. Montaruli, E. Silvestro, and S. Sciascia Antiphospholipid syndrome in northwest Italy (aps piedmont cohort): demographic features, risk factors, clinical and laboratory profile Lupus 21 2012 806 809
20. M. Etemadifar, L. Dehghani, S. Tahani, N. Toghianifar, M. Rahaimi, and N. Eskandari Neurological manifestations in patients with antiphospholipid syndrome Iran J Neurol 12 2013 172 175
21. T. Marchetti, M. Cohen, J.C. Gris, and P. de Moerloose Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand? Pol Arch Med Wewn 123 2013 713 720
22. P.G. De Groot, J.C. Meijers, and R.T. Urbanus Recent developments in our understanding of the antiphospholipid syndrome Int J Lab Hematol 34 2012 223 231
23. V.X. Du, H. Kelchtermans, P.G. de Groot, and B. de Laat From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome Thromb Res 132 2013 319 326
24. D. Erkan, E. Kozora, and M.D. Lockshin Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome Pathophysiology 18 2011 93 102
25. J.A. Gomez-Puerta, R. Cervera, L.M. Calvo, B. Gomez-Anson, G. Espinosa, and G. Claver Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients Rheumatology (Oxford) 44 2005 95 99
26. M.G. Tektonidou, N. Varsou, G. Kotoulas, A. Antoniou, and H.M. Moutsopoulos Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings Arch Intern Med 166 2006 2278 2284
27. K. Panichpisal, E. Rozner, and S.R. Levine The management of stroke in antiphospholipid syndrome Curr Rheumatol Rep 14 2012 99 106
28. M. Nishimura, T. Nii, G. Trimova, S. Miura, K. Umezawa, and A. Ushiyama The NF-kappaB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome J Nephropathol 2 2013 114 121
29. P.G. Vlachoyiannopoulos, and J.G. Routsias A novel mechanism of thrombosis in antiphospholipid antibody syndrome J Autoimmun 35 2010 248 255
30. K. Oku, O. Amengual, and T. Atsumi Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome Eur J Clin Invest 42 2012 1126 1135
31. M. Taraborelli, L. Andreoli, and A. Tincani Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease' Best Pract Res Clin Rheumatol 26 2012 79 90
32. M.S. Santos, J.F. de Carvalho, M. Brotto, E. Bonfa, and F.A. Rocha Peripheral neuropathy in patients with primary antiphospholipid (Hughes') syndrome Lupus 19 2010 583 590
33. R. Forastiero Bleeding in the antiphospholipid syndrome Hematology 17 Suppl. 1 2012 S153 S155
34. C. Lopez-Pedrera, P. Ruiz-Limon, M.A. Aguirre, N. Barbarroja, C. Perez-Sanchez, and P. Buendia Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome Ann Rheum Dis 70 2011 675 682
35. C. Lopez-Pedrera, P. Ruiz-Limon, M.A. Aguirre, A. Rodriguez-Ariza, and M.J. Cuadrado Potential use of statins in the treatment of antiphospholipid syndrome Curr Rheumatol Rep 14 2012 87 94
36. A. Schmidt-Tanguy, J. Voswinkel, D. Henrion, J.F. Subra, L. Loufrani, and V. Rohmer Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients J Thromb Haemost 11 2013 1927 1929
37. S. Sciascia, O. Giachino, and D. Roccatello Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin Clin Exp Rheumatol 30 2012 409 413
38. S. Tenti, G.M. Guidelli, F. Bellisai, M. Galeazzi, and A. Fioravanti Long-term treatment of antiphospholipid syndrome with intravenous immunoglobulin in addition to conventional therapy Clin Exp Rheumatol 31 2013 877 882